Categories: News

Ibogaine By David Dardashti Appoints Whitney Nuckolls for Aftercare Support for Women

Ibogaine By David Dardashti Creates an Aftercare Support Network for Women

Ibogaine support for Women

Whitney is excited to help ibogaine clinic expand

MIAMI, April 27, 2024 (GLOBE NEWSWIRE) — Ibogaine By David Dardashti (IBDD) is pleased to announce the appointment of Whitney Nuckolls as the Alumni Coordinator of their free aftercare support network for women.

IBDD is always looking for innovative ways to support their clients, and this new program is a testament to that commitment. The clinic understands that there are gender specific issues that women do not always feel comfortable discussing in the presence of men. To help address this need, IBDD has decided to appoint Whitney as the coordinator for a free aftercare support network for women who have undergone ibogaine treatment at the clinic. At this time, we are not sure of the exact shape and scope of this program. We will begin by offering women who have received ibogaine treatment at our clinic the opportunity to join a WhatsApp group. We anticipate that this support network will expand as the program progresses. Whitney had this to say about her new role, “I am very excited and honored to be part of this new initiative. It is a great opportunity to create a safer and more supportive space for women who have gone through ibogaine treatment. I am always willing to support ibogaine in any way I can.”

Ibogaine By David Dardashti has appointed Whitney as the coordinator for a free aftercare support network for women who have undergone ibogaine treatment, which will include a WhatsApp group to provide a safer and more supportive space.

We encourage those who are interested in this program to reach out to IBDD to learn more. We also look forward to the potential growth of this program as we receive more feedback and create tailored solutions for our clients.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/db90f9fd-66be-419a-a51b-7c9bb2804f94

CONTACT: Gavriel Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

10 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

13 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

13 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

13 hours ago